A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study



Status:Terminated
Conditions:Orthopedic
Therapuetic Areas:Orthopedics / Podiatry
Healthy:No
Age Range:18 - 57
Updated:4/21/2016
Start Date:December 2014
End Date:January 2015

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Long-term Efficacy Assessment Following Initial Scar Revision Surgery And Phase 2 Open-label Study To Evaluate Safety Of Re-treatment With Pf-06473871

Study is a multicenter, two-part, open-label phase II study in adults, evaluating the safety
and long-term efficacy of PF-06473871 one year after surgical revision and treatment with
PF-06473871.


Inclusion Criteria:

- Subjects previously randomized to Pfizer clinical study B5301001.

- Subjects must be able to tolerate up to a 3 hour scar revision surgery under sedation
and local anesthesia.

Exclusion Criteria:

- Pregnant female subject; breastfeeding female subjects; male subjects with partners
currently pregnant.

- Any previous history of intolerable adverse reactions to PF-06473871, such as serious
adverse events attributed to study drug or having been withdrawn due to AE in
prerequisite study B5301001.
We found this trial at
5
sites
Primeter outpatient surgery center
Atlanta, Georgia 30328
2171
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Kavali Plastic Surgery and Skin Renewal Center
Atlanta, Georgia 30328
2171
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Stephan Baker, MD PA
Coral Gables, Florida 33146
2731
mi
from 98109
Coral Gables, FL
Click here to add this to my saved trials
Bayside Ambulatory Center
Miami, Florida 33133
2732
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Body Aesthetic Research Center
Saint Louis, Missouri 63141
1706
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials